IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
696.64
-10.01 (-1.42%)
Nov 10, 2026, 4:00 PM EST - Market closed

IDEXX Laboratories Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,6624,3043,8983,6613,3673,215
Revenue Growth
11.87%10.42%6.46%8.72%4.73%18.80%
Gross Profit
2,9242,6602,3792,1902,0041,889
Operating Income
1,5151,3601,1901,097898.77932.03
Net Income
1,1821,059887.87845.04679.09744.85
Earnings Per Share
14.8313.0810.6710.068.038.60
EPS Growth
17.70%22.59%6.06%25.28%-6.63%28.17%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
IDEXX VetLab Consumables
1,6751,4971,3031,1881,0571,007
Rapid Assay Products
351.69348.95359.75344.49313.67296.85
Reference Laboratory Diagnostic & Consulting
1,5411,4241,3361,2791,1781,124
CAG Diagnostics Services & Accessories
143.91137.42130.37124.05111.26107.27
CAG Diagnostics Capital - Instruments
199.25200.21131.93137.6147.33149.14
Veterinary Software, Services & Diagnostics
375.44345.88312.62279.33251.19206.26
Water Segment
218.2201.15185.11168.15155.72146.51
LPD Segment
139.98131.79122.06121.66122.61135.89
Other
17.3217.4816.2918.7930.243.01
Revenue (Total)
4,6624,3043,8983,6613,3673,215

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
197.54180.07288.27453.93112.55144.45
Total Debt
972.96976.51986.951,0671,4701,031
Net Cash (Debt)
-775.43-796.44-698.68-613.42-1,357-886.56
Net Cash Growth
------
Net Cash Per Share
-9.72-9.83-8.39-7.30-16.05-10.24

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,4191,182929906.51542.98755.55
Capital Expenditures
-114.99-124.68-120.92-133.63-148.84-119.55
Free Cash Flow
1,3041,057808.08772.88394.15636
Free Cash Flow Growth
35.32%30.82%4.55%96.09%-38.03%17.54%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.72%61.80%61.04%59.82%59.52%58.76%
Operating Margin
32.50%31.60%30.53%29.97%26.69%28.99%
Pretax Margin
31.72%30.77%28.48%28.99%25.54%28.07%
Profit Margin
25.36%24.62%22.78%23.08%20.17%23.16%
FCF Margin
27.97%24.56%20.73%21.11%11.71%19.78%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
46.9750.9938.1354.5549.7574.96
Forward PE
42.6248.0335.3551.9344.2573.77
P/FCF Ratio
42.0951.1041.9059.6485.7287.79
PS Ratio
11.7712.558.6912.5910.0317.36